FDA 510(k)
FDA class 2
Substantially Equivalent
🇫🇷 France
VIDAS LYME IGG
K Number: K122986
·
Decision Mar 5, 2013
Classifications
1
FEI Numbers
30
Registration Numbers
30
Same Product Code
110
Applicant Total
16
Review Days
160
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- VIDAS LYME IGG
- K Number
- K122986
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.3830
- Medical Specialty
- Microbiology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Biomerieux S.A.
- Date Received
- September 26, 2012
- Decision Date
- March 5, 2013
- Product Code
- LSR
- Advisory Committee
- Microbiology
- Review Advisory Committee
- MI
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LSR | Reagent, Borrelia Serological Reagent | FDA class 2 | Microbiology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (LSR), ordered by most recent decision date.
Lyme-ID IgG Test; Bio-ID800
FDA 510(k)
FDA Class 2
·Microbiology
iDart Lyme IgM ImmunoBlot Kit
FDA 510(k)
FDA Class 2
·Microbiology
iDart Lyme IgG ImmunoBlot Kit
FDA 510(k)
FDA Class 2
·Microbiology
ZEUS Solinas Borrelia VlsE1/pepC10 IgG/IgM Test System; ZEUS Solinas Borrelia VlsE1/pepC10 IgG/IgM Control Kit
FDA 510(k)
FDA Class 2
·Microbiology
Viramed Borrela All-In-One ViraChip Test Kit
FDA 510(k)
FDA Class 2
·Microbiology
Gold Standard Diagnostics Borrelia burgdorferi IgG ELISA Test Kit
FDA 510(k)
FDA Class 2
·Microbiology
Other Clearances by Biomerieux S.A.
| K Number | Device Name | ||
|---|---|---|---|
| K250274 | ETEST Imipenem/Relebactam P. aeruginosa (IRPA) (0.008/4-128/4 µg/mL) | Apr 30, 2025 | Substantially Equivalent |
| K210757 | ETEST Fosfomycin (FO) (0.032-512 µg/mL) | Nov 12, 2021 | Substantially Equivalent |
| K192738 | ETEST Delafloxacin (DFX) (0.002-32 µg/mL) | Nov 26, 2019 | Substantially Equivalent |
| K192050 | ETEST Eravacycline (ERV) (0.002 32 µg/mL) | Sep 27, 2019 | Substantially Equivalent |
| K191953 | ETEST Imipenem/Relebactam (IPR) (0.002/4-32/4 ug/mL) | Aug 22, 2019 | Substantially Equivalent |
| K190154 | ETEST Piperacillin/Tazobactam (P/T) (0.016/4-256/4 ug/mL) | May 1, 2019 | Substantially Equivalent |
| K183031 | ETEST Meropenem/Vaborbactam (MEV) (0.004/8-64/8 µg/mL) | Jan 11, 2019 | Substantially Equivalent |
| K181092 | CHROMID CARBA agar (CARB) | Jul 6, 2018 | Substantially Equivalent |
| K180936 | ETEST Telavancin (TLA) (0.002-32 ug/mL) | Jul 3, 2018 | Substantially Equivalent |
| K162385 | RAPIDEC CARBA NP | Apr 27, 2017 | Substantially Equivalent |